CLINICAL_TRIALS ClinicalTrials.gov record update

Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03013543
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:37.452891+00:00
Published At: 2023-08-18T00:00:00+00:00
Record Updated At: 2023-08-18
Results Posted At: 2023-08-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Genetic Obesity", "Obesity", "Obesity Due to Melanocortin 4 Receptor Deficiency"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-08-18"
protocolSection.identificationModule.nctId: "NCT03013543"
protocolSection.identificationModule.officialTitle: "Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-08-18"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.